Post Job Free

Resume

Sign in

Chief Nuclear Medicine Technologist

Location:
Buffalo, NY
Posted:
March 01, 2021

Contact this candidate

Resume:

Scott Wisniewski

CHIEF TECHNOLOGIST NUCLEAR MEDICINE

Profile

Professional manager and nuclear medicene technologist with over 20 years of experience in supervisory, leadership, clinical and patient care roles. Experience overseeing all aspects of Imaging Services, including policies, procedures, studies, and treatments. Proven record of leading cooperative working relationships with staff, physicians, radiologists, and administrative professionals to ensure well-integrated systems. Demonstrates a strong ability to interact with both patients and co-workers, while displaying a high level of caring, listening, dignity and respect. Able to work as a team member within the department and all other departments to expedite patient care efficiently.

Employment History

Chief Technologist, UBMD - Nuclear Medicine - Molecular Diagnostics, Amherst

F EBRUARY 2 0 1 2 — PRESENT

• Oversee and conduct comprehensive PET/CT studies for oncology, epilepsy and Alzheimer patients.

• Prepare and inject radionuclides into patients.

• Mantain and supervise proper maintenance of dose logs, isotope records and disposal of radioactive waste.

• Oversee patient schedules to monitor for efficiency and productivity while ensuring highest level of patient care.

• Instruct and supervise nuclear medicine students in clinical practicum.

• Assist with recertification process of all accreditations. Update and revise Policy and Procedure manuals, as needed.

• Manage the process of ordering supplies and keep accurate inventory of stock. Communicate and maintain business relationships with supply vendors.

• Provide support of networking cameras, computers, and printers. Chief Technologist, UBMD - Advanced Molecular Imaging Services, Amherst

F EBRUARY 2 0 0 1 — F EBRUARY 2 0 1 2

• Handle and conduct comprehensive CT/PET studies.

• Administer radioisotope intravenously to detect or treat diseases, using radioisotope equipment, under the direction of a physician.

• Detect and map radiopharmaceuticals in patients’ bodies, using a camera to produce photographic or computer images.

• Produce a computer-generated film image for interpretation by a physician.

• Maintain and calibrate radioisotope and laboratory equipment.

• Dispose of radioactive materials and store radiopharmaceuticals, following radiation safety protocols.

Details

21 Dennybrooke Lane

West Seneca, 14224

716-***-****

adkk22@r.postjobfree.com

Skills

Leadership

Ability to Work in a Team

Ability to Multitask

Fast Learner

Effective Time Management

Reason and Problem Solve

Perceive and Visualize

Patient Care

Radiology

Nuclear Medicine

Radiation Safety

Detail Oriented

Interpersonal and

Communication Skills

CT/PET Imaging

Compassionate

Leadership Skills

Management Skills

Physical Stamina

Advanced Technology

Active Listening

Reading Comprehension

Social Perceptiveness

Languages

English

Certified Nuclear Medicine Technologist, Buffalo Cardiology and Pulmonary Associates, P.C., Williamsville

MAY 1 9 9 9 — F EBRUARY 2 0 0 1

• Perform cardiac PET and general cardiac studies with high level of care as a radiation safety officer.

• Supervise the shipment and receiving of patient doses for PET/CT exams while updating all files related to radiation safety and patient records.

• Perform all quality control checks on imaging and non-imaging equipment to ensure proper performance and functioning.

• Assist patients by explaining procedures and the care process.

• Assist with ordering supplies and maintaining maintaining inventory. Education

Certification: Computed Tomography, State University of New York at Buffalo

JANUARY 2 0 1 3 — APRIL 2 0 1 4

Bachelor of Science: Nuclear Medicine Technology, State University of New York at Buffalo

S E P T EMBER 1 9 9 7 — MAY 1 9 9 7

Associate of Science: Liberal Arts, Erie Community College, Orchard Park S E P T EMBER 1 9 9 5 — MAY 1 9 9 7

References

Lynn Chwokdak, PharmD, RPh from SOFIE

adkk22@r.postjobfree.com 716-***-****

Daniel Guarasci, MS, PharmD, BCNP, DABSNM from CRS Nuclear Services adkk22@r.postjobfree.com 716-***-****

Michael Hammersmith, MS, DABR, DABSNM from Advanced Medical Physics, PLLC

adkk22@r.postjobfree.com 716-***-****

Certifications

Nuclear Medicine Technology Certification

The American Registry of Radiologic Technologists (AART-CT) Computed Tomography

American Heart Association: BLS-CPR Certification

Northwest Imaging Forums - PET/CT Certification

Research, Abstracts and Multi-Center Clinical Trials

• A Randomized, Double-Blind, Placebo-Controlled, Two Cohort Parallel Group Study to Evaluate The Efficacy of CAD106 and CNP520 in Preclinical Alzheimer’s Disease Participants At Risk For The Onset Of Clinical Symptoms. Sponsor: Novartis/Bioclinica. Current Study.

• Effect of LY3202626 on Alzheimer’s Disease Progression as Measured by Cerebral 18F-AV-1451 Tau- PET in Mild Alzheimer’s Disease Dementia. Sponsor: MNI/Eli Lilly and Company 17X-MC-LLCF.

• A Phase 26/3 Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Investigating The Efficacy and Safety of JNJ-54861911 in Subjects Who Are Asymptomatic At Risk for Developing Alzheimer’s Dementia. Sponsor: MNI/ Janssen 54861911 ALZ2003

• Amyloid (18F-Av-45) Alzheimer’s Disease Neuroimaging Initiative Study

(ADNI). Sponsor: National Institute of Health/ADCS. MCCT

• Effect of Passive Immunization on the Progression of Alzheimer’s Disease: Solanezumab (LY2062430) versus Placebo. Sponsor: Eli Lilly. MCCT

• Comparison of 124Iodine PET/CT with 131Iodine Whole Body Gamma Scintigraphy and 18F-fluorodeoxyglucose PET in Differentiated Thyroid Carcinoma. RESEARCH

• Metabolic Cerebral Imaging in Incipient Dementia: Early and Long Term Value of Imaging Brain Metabolism. Principal Investigator Daniel H. Silverman, MD, Ph.D. UCLA Medical Center. MCCT

• Comparative study of 18F-fluorodeoxyglucose PET and 67GaCitrate imaging to predict early response to chemotherapy in patients with non-Hodgkin’s Lymphoma.RESEARCH

• Comparative study of 18F Fluoride PET and 99mTc-MDP detecting Avascular Necrosis. RESEARCH

• Comparative study of known bone metastases in patients with primary breast cancer using 18F Fluoride PETimaging versus high energy collimator gamma camera imaging. RESEARCH

• Regional Cerebral Metabolism with Sleep Apnea: A PET 18F-fluorodeoxyglucose Study. Daniel Rifkin, MD. RESEARCH

• Computer Assisted Spect Imaging of Cerebral Small Vessel Disease. RESEARCH

• Contribution of CT Bone Window to 18F-fluorodeoxyglucose PET in the Assessment of Osseous Metastases. Mohei Abou-Zied, MD. ABSTRACT

• Preliminary Clinical Application of 11C-Choline PET in Prostate Cancer Patients. RESEARCH

• Tumor Hypoxia Imaging with 62Cu-ATSM: A Pilot Study. RESEARCH

• 18F-fluorodeoxyglucose PET/CT in Detection of Diabetic Foot Osteomyelitis. RESEARCH

• Quantitative Measurement of Amyloid Plaques with Positron Emission Tomography and Expression of Amyloid Precursor Protein in Mononuclear Cells and Adipose Tissue of Hypogonadal Men with Type 2 Diabetes. RESEARCH

• Detection of Neuroendocrine Tumors: 11C-Hydroxyephedrine Compared to 111In-Pentetreotide Scintigraphy. RESEARCH1.



Contact this candidate